Brazil HIV Advocates Predicted USAID Cuts: Lessons for Global 2026

Brazil's HIV advocates predicted USAID funding cuts, and their foresight offers critical lessons for global health sustainability. In a recent session at the Aids 2026 conference in Rio de Janeiro, Juliana Cesar, political liaison coordinator at the Brazilian HIV NGO Gestos, explained that the dissolution of USAID, while feeling like a rupture, was an anticipated trend. Brazil's unique position—having a constitutionally guaranteed right to healthcare since 1988—has enabled it to build an HIV prevention and treatment system independent of foreign aid, but the country still faces challenges with pharmaceutical pricing and research funding cuts.

How Brazil Achieved HIV Independence

Brazil's Unified Health System (SUS) has been pivotal in achieving milestones such as eliminating HIV transmission to newborns in 2025. This independence was not accidental; it was the result of decades of civil society advocacy. After the 1988 constitution, activists ensured that HIV prevention and treatment were earmarked in national budgets, making them a permanent priority. Cesar emphasized that this budgeting commitment is why Brazil could withstand donor withdrawal better than many other nations.

However, Brazil's path was not without trade-offs. The country once implemented a Financial Transaction Tax to fund public health, but it was abolished in 2007 amid a political shift to the right. Cesar acknowledged that the tax was regressive, applying the same rate to all citizens regardless of income, yet it demonstrated a creative approach to sustainable health financing.

Challenges Remain: Pharma and Research Cuts

Despite its robust system, Brazil still negotiates with pharmaceutical companies for access to the latest HIV preventions and treatments. Additionally, NIH funding cuts could curtail HIV-related research in Brazil, potentially slowing innovation. Cesar pointed out that while Brazil is independent in service delivery, it remains dependent on global research and drug pricing structures.

Advocates like Gestos have long urged other countries to adopt similar measures to reduce reliance on foreign aid. Cesar's warning—"We would see the trends"—underscores the need for proactive planning rather than reactive crisis management.

Comparative Analysis: Brazil vs. USAID-Dependent Countries

Key Takeaways for Global Health Advocates

• Constitutional protection of healthcare rights creates long-term stability.
• Budget earmarking ensures consistent funding regardless of political shifts.
• Innovative financing like transaction taxes can be effective but must be equitable.
• Pharmaceutical negotiations require global cooperation to ensure fair access.
• Research independence is crucial for sustaining progress.

FAQ